Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer (Q38453565)
Jump to navigation
Jump to search
scientific article published on June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer |
scientific article published on June 2015 |
Statements
1 reference
Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer (English)
1 reference
Sarayut L Geater
Chong-Rui Xu
Caicun Zhou
Cheng-Ping Hu
Jifeng Feng
Shun Lu
Wei Li
Mei Hou
Jian Hua Shi
Kye Young Lee
Michael Palmer
Yang Shi
Juliane Lungershausen
1 June 2015
1 reference